Clinical Trials Logo

Chronic Obstructive Pulmonary Disease clinical trials

View clinical trials related to Chronic Obstructive Pulmonary Disease.

Filter by:

NCT ID: NCT02845752 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease

Start date: March 1, 2017
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether exercise can be prolonged in COPD can by the inhaled bronchodilator Stiolto Respimat. The study will identify whether any endurance benefit is due to reduction in fatigue that originates within the skeletal muscles and/or from effects on neural activation of the skeletal muscles.

NCT ID: NCT02842463 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Chronicle Obstructive Pulmonary Disease

6STaR
Start date: July 2016
Phase:
Study type: Observational

The purpose of this study is to determine, if it exists, a relation between plateau heart rate from the last 3 minutes of the 6-minute stepper test and heart rate from first ventilatory threshold from cardiopulmonary exercise testing in order to individualise pulmonary rehabilitation in patients with mild to moderate chronicle obstructive pulmonary disease.

NCT ID: NCT02838108 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease (COPD)

The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort

Start date: October 2016
Phase:
Study type: Observational

This is an observational study examining outcomes and treatment patterns in a community-based cohort of subjects with Chronic obstructive pulmonary disease (COPD) who are based in the Kannapolis, NC area.

NCT ID: NCT02833480 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota

DISARM
Start date: February 2015
Phase: Phase 2
Study type: Interventional

This study will evaluate the effects of budesonide (using Symbicort which is budesonide and formoterol) and fluticasone (using Advair which is fluticasone and salmeterol) on the airway microorganisms of patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). This is a randomized, parallel group, two-centered clinical trial study to evaluate the effects of a 12 week treatment with Symbicort 400 mcg BID and Advair 250 mcg BID (via Diskus) on airway microbiota in patients with moderate-to-severe COPD. The control arm of this study will be Oxeze 12 ug BID.

NCT ID: NCT02832739 Active, not recruiting - Diabetes Mellitus Clinical Trials

Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness

USECARE
Start date: November 2016
Phase: N/A
Study type: Interventional

The aim of the USECARE project is to improve and test SENACA, an ICT-based self-management support system for chronically ill patients and informal caregivers. 60 end-users will be instructed to use SENACA for approx. 3 months (in Israel and Norway). Amongst others, clinical and behavioural outcomes will be recorded. Additionally, SENACA's usability will be evaluated to determine its potential future scalability.

NCT ID: NCT02827929 Completed - Asthma Clinical Trials

Efficacy of Education Programs in Patients With Chronic Airway Diseases

Start date: June 2014
Phase: N/A
Study type: Interventional

The objective of this study is to determine whether the systematic education on air way disease and inhalers in outpatient settings contributes to improve the quality of life. Education has been known to be effective for management of chronic airway disease. However, the real benefits remain unclear. An organized education on the chronic airway disease is directed by primary care physicians, and the investigators evaluate the effectiveness of the education.

NCT ID: NCT02827721 Recruiting - COPD Clinical Trials

Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Start date: July 2015
Phase:
Study type: Observational

Current guideline-based criteria defining COPD do not meet the challenges set by the complex pathophysiology of the disease. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of COPD.

NCT ID: NCT02826265 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

Start date: January 2016
Phase:
Study type: Observational

Current diagnostic tools used in pulmonary disease often do not meet the challenges set by the respective pathophysiology. The investigators therefore aimed to evaluate novel or not widely used diagnostic approaches for the detection and therapeutic monitoring of patients with various pulmonary diseases.

NCT ID: NCT02825043 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

HFNC Effect on BCSS in Patients With COPD

COPD
Start date: February 2016
Phase: N/A
Study type: Interventional

The primary objective of this study is to look for a correlation between the use of high-flow nasal cannula in the outpatient setting in patients with previous chronic obstructive pulmonary disease exacerbation and the change in their Breathlessness, Cough, and Sputum Scale score. The hypothesis is that home use of high-flow nasal cannula will lead to a reduction in Breathlessness, Cough, and Sputum Scale score by 1.3.

NCT ID: NCT02824809 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Association Between Testosterone Levels and COPD Severity

COPDTESTO
Start date: June 2016
Phase: N/A
Study type: Observational

The Aims of the study are estimate the association between the severity of COPD and free testosterone level and the prevalence of hypogonadism in adult men with stable COPD